LenioBio (private company)

See something wrong or missing? Let us know
Offices:Dusseldorf
Business model:B2B

LenioBio develops rapid plant-based, cell-free protein expression that scales for research, development and production.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 13.12M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to LenioBio

Name Criteria
Denmark Cytoki Pharma
60%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Norway Alginor
60%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany Exciva
60%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany Emergence Therapeutics
60%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Pila Pharma
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Intrance Medical Systems
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Switzerland Galventa
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
United Kingdom Mytos
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Oncorena
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Denmark Ferrosan Medical Devices
50%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
Top